MONODOX
Clinical safety rating: caution
Comprehensive clinical and safety monograph for MONODOX (MONODOX).
Doxycycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, blocking the attachment of aminoacyl-tRNA to the mRNA-ribosome complex.
| Metabolism | Metabolized primarily in the liver via glucuronidation; does not undergo significant CYP450-mediated metabolism. |
| Excretion | Renal: ~40% (glomerular filtration, tubular secretion); biliary: ~20-60% (enterohepatic circulation); fecal: ~30% (unabsorbed or excreted in bile). |
| Half-life | Terminal elimination half-life: 14-22 hours (mean ~18 hours) in adults; prolonged up to 24-48 hours in renal impairment; no dose adjustment in mild-moderate renal impairment but caution in severe (CrCl <30 mL/min). |
| Protein binding | 88-96% bound to plasma proteins (primarily albumin, also lipoproteins). |
| Volume of Distribution | 1.3-1.8 L/kg (extensive tissue penetration; distributes into bone, teeth, liver, spleen, pleural fluid, synovial fluid, and CSF (inflamed meninges)). |
| Bioavailability | Oral (fasting): 95-100% (food reduces absorption by ~10-20%); IV: 100%. |
| Onset of Action | Oral: 1-2 hours (time to peak serum concentration ~2-4 hours); IV: immediate upon completion of infusion. |
| Duration of Action | 12-24 hours (bacteriostatic effect persists, trough levels maintained with twice-daily dosing; longer for renal elimination). |
| Molecular Weight | 444.44 |
| Action Class | Tetracyclines |
| Brand Substitutes | Doxid 100mg Tablet, Rapidoxyn 100mg Tablet, Doxygee 100mg Tablet, Doxytop 100mg Tablet, Detab Tablet, G Dox Capsule, Duradox Capsule, Doxycyline Capsule |
100 mg orally or IV every 12 hours on day 1, then 100 mg orally or IV every 24 hours; for severe infections, 100 mg every 12 hours.
| Dosage form | CAPSULE |
| Renal impairment | No dose adjustment required in mild to moderate renal impairment; avoid use in severe renal impairment (CrCl <10 mL/min) due to anti-anabolic effects; if necessary, reduce dose or extend dosing interval. |
| Liver impairment | Child-Pugh A: no adjustment; Child-Pugh B: reduce dose by 50% or extend interval; Child-Pugh C: contraindicated or use with extreme caution at reduced dose. |
| Pediatric use | For children ≥8 years: 4.4 mg/kg orally or IV on day 1 (divided every 12 hours), then 2.2 mg/kg once daily; maximum 100 mg/day. Not recommended for children <8 years due to permanent tooth discoloration. |
| Geriatric use | Use lowest effective dose due to increased risk of photosensitivity, gastrointestinal effects, and potential for drug accumulation; monitor renal function; no specific dose adjustment recommended for elderly with normal renal function. |
| 1st trimester | Contraindicated due to risk of fetal skeletal and tooth development interference, neural tube defects, and other malformations. Potential for maternal hepatotoxicity. |
| 2nd trimester | Avoid use; may cause permanent tooth discoloration (yellow-gray-brown) and enamel hypoplasia in the fetus. Also inhibits bone growth. |
| 3rd trimester | Avoid use; same risks as second trimester. Additionally may cause fatty liver in pregnant women. |
Clinical note
Comprehensive clinical and safety monograph for MONODOX (MONODOX).
| Placental transfer | Doxycycline crosses the placenta readily; fetal serum levels reach 20-60% of maternal levels. Binding to fetal tissues and bones occurs. |
| Breastfeeding | Monodox (doxycycline) is excreted in breast milk in low concentrations. Theoretical risk of tooth staining and bone growth suppression in the nursing infant. American Academy of Pediatrics considers use compatible with breastfeeding for short-term use (<3 weeks), but caution is advised. Monitor infant for gastrointestinal disturbances and rash. |
■ FDA Black Box Warning
No FDA black box warning identified.
| Serious Effects |
Hypersensitivity to doxycycline or any tetracyclinePregnancy (especially after first trimester except for anthrax or other life-threatening conditions)Children under 8 years of age (risk of permanent tooth discoloration and bone growth inhibition)Severe hepatic impairment
| Precautions | Risk of tooth discoloration and enamel hypoplasia in children under 8 years old, Risk of photosensitivity (exaggerated sunburn reaction), Risk of esophageal ulceration (take with adequate fluids), Hepatotoxicity (rare), Pseudomembranous colitis (Clostridioides difficile-associated diarrhea), Intracranial hypertension (pseudotumor cerebri), Use during pregnancy may cause fetal harm, Inhibition of bone growth in premature infants |
| Food/Dietary | Take with food if gastric upset occurs; however, avoid dairy products (milk, yogurt, cheese), calcium-fortified juices, antacids, and iron supplements as they reduce absorption. Separate by at least 2 hours. |
Loading safety data…
| Lactation Rating | L2 (Safer if <3 weeks use) |
| Teratogenic Risk | FDA Pregnancy Category D. Tetracyclines cross placenta. First trimester: No increased risk major malformations from limited human data; animal studies show skeletal anomalies. Second and third trimesters: Avoid due to risk of permanent tooth discoloration (yellow-gray-brown) and enamel hypoplasia; also inhibit fetal bone growth. Increased risk of maternal hepatotoxicity and pancreatitis. |
| Fetal Monitoring | Monitor maternal hepatic function (LFTs) and renal function. Fetal ultrasound for skeletal development if exposure in 2nd/3rd trimester. Assess infant for jaundice, tooth discoloration after birth. |
| Fertility Effects | No known adverse effects on human fertility. Animal studies do not indicate impaired fertility. Tetracyclines may decrease spermatogenesis at high doses in animals, but clinical significance unclear. |
| Clinical Pearls | Monodox (doxycycline monohydrate) has high oral bioavailability unaffected by food; avoid dairy within 2 hours of dosing due to calcium chelation. Use sunscreen actively to prevent phototoxic reactions. In acne, therapeutic response may take 2-4 weeks. Monitor for esophageal ulceration; instruct patients to take with full glass of water and remain upright for 30 minutes. |
| Patient Advice | Take with a full glass of water and stay upright for 30 minutes to prevent esophageal irritation. · Avoid dairy products, antacids, iron, or calcium supplements within 2 hours of taking this medication. · Use sunscreen and protective clothing; avoid prolonged sun exposure as this drug increases sunburn risk. · Complete the full prescription even if you feel better; do not skip doses. · May cause diarrhea; if severe or bloody, contact your doctor immediately. · Do not take with isotretinoin or other tetracyclines. · If you are pregnant, planning to become pregnant, or breastfeeding, discuss with your doctor before use. |